OAMU
ABBV icon

Ostrum Asset Management US’s AbbVie ABBV Stock Holding History

Ostrum Asset Management US’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,239
Closed -$1.04M – 36
2018
Q4 		$1.04M Buy
+11,239
New +$988K 0.15% 84

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ostrum Asset Management US's ABBV Position: Q1 2019 in Review

Ostrum Asset Management US sold out of AbbVie (ABBV) in Q1 2019, closing a stake of 11,239 shares — an estimated $1.04M sold.

Ostrum Asset Management US first reported a position in ABBV in Q4 2018 and held it in 1 quarter. The position peaked at $1.04M in Q4 2018. 2,034 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

  • Ostrum Asset Management US reported no remaining AbbVie position as of Q1 2019 after selling out during the quarter.
  • Ostrum Asset Management US sold 11,239 AbbVie shares in Q1 2019, an estimated $1.04M.
  • Ostrum Asset Management US first reported a position in AbbVie in Q4 2018 and held it in 1 quarter.
  • Ostrum Asset Management US's AbbVie position peaked at $1.04M in Q4 2018.
  • 2,034 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Ostrum Asset Management US's 13F filing for Q1 2019, filed 15 May 2019.